tiprankstipranks
Trending News
More News >
Meghmani Organics Limited (IN:MOL)
:MOL
India Market
Advertisement

Meghmani Organics Limited (MOL) AI Stock Analysis

Compare
0 Followers

Top Page

IN:MOL

Meghmani Organics Limited

(MOL)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
₹79.00
▼(-0.40% Downside)
The overall stock score is primarily influenced by financial performance challenges, including declining revenues and negative cash flows. Technical analysis suggests potential downward pressure, while valuation metrics indicate possible overvaluation. The absence of earnings call data and corporate events did not impact the score.

Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)

Meghmani Organics Limited Business Overview & Revenue Model

Company DescriptionMeghmani Organics Limited (MOL) is a leading manufacturer and supplier of a diverse range of chemical products, primarily focusing on agrochemicals, pigments, and specialty chemicals. Established in India, the company operates in multiple sectors including agriculture, textiles, and coatings, providing innovative solutions through its extensive portfolio that includes herbicides, insecticides, and various organic pigments used in industrial applications.
How the Company Makes MoneyMeghmani Organics generates revenue through the production and sale of its core products, which include agrochemicals and pigments. The company's revenue model is primarily based on direct sales to distributors, wholesalers, and manufacturers in both domestic and international markets. Key revenue streams stem from the agrochemical sector, where it leverages its research and development capabilities to create effective crop protection solutions. Additionally, the company benefits from long-term contracts and strategic partnerships with agricultural firms and industrial manufacturers, enhancing its market reach and stability. The global demand for sustainable and eco-friendly chemicals also contributes positively to its earnings, allowing MOL to capitalize on emerging market trends.

Meghmani Organics Limited Financial Statement Overview

Summary
Meghmani Organics Limited is facing financial challenges characterized by declining revenues, negative net income, and high leverage. While there are some improvements in operational margins, the overall financial health is strained by negative cash flows and profitability inefficiencies.
Income Statement
45
Neutral
The company displays declining revenue with negative growth in the recent year. Gross and net profit margins have been volatile, with the latest year showing a negative net income, impacting the overall profitability. While the EBIT margin has improved, EBITDA margin remains relatively low, indicating potential operational inefficiencies.
Balance Sheet
55
Neutral
The balance sheet shows a high debt-to-equity ratio, suggesting increased leverage and potential financial risk. The equity ratio is moderate, reflecting a balanced asset financing structure. Return on equity has been negative recently, indicating challenges in generating shareholder value.
Cash Flow
40
Negative
The cash flow statement reveals negative free cash flow over the past years, signaling potential liquidity issues. The operating cash flow is insufficient to cover capital expenditures, affecting the company's ability to fund operations without external financing. The free cash flow to net income ratio highlights a disconnect between profitability and cash generation.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue22.79B21.24B15.48B25.28B24.73B16.12B
Gross Profit9.00B8.60B5.21B4.79B10.01B6.93B
EBITDA2.34B1.87B119.50M4.10B4.81B3.11B
Net Income188.41M-106.01M-1.06B2.38B3.04B1.86B
Balance Sheet
Total Assets0.0030.85B30.40B31.98B27.98B19.74B
Cash, Cash Equivalents and Short-Term Investments226.82M227.24M330.74M1.52B117.22M1.23B
Total Debt0.008.29B8.37B8.24B4.99B2.68B
Total Liabilities-15.15B15.70B15.12B15.29B13.31B8.01B
Stockholders Equity15.15B15.15B15.28B16.69B14.66B11.73B
Cash Flow
Free Cash Flow0.00-226.88M-165.29M-2.61B-1.79B1.24B
Operating Cash Flow0.00662.22M2.50B2.04B648.32M3.33B
Investing Cash Flow0.00309.70M-1.78B-4.18B-1.33B-3.07B
Financing Cash Flow0.00-913.88M-854.77M2.34B577.19M-142.40M

Meghmani Organics Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price79.32
Price Trends
50DMA
81.66
Negative
100DMA
87.86
Negative
200DMA
81.00
Negative
Market Momentum
MACD
-1.53
Positive
RSI
28.64
Positive
STOCH
5.84
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Negative. The current price of 79.32 is below the 20-day moving average (MA) of 79.94, below the 50-day MA of 81.66, and below the 200-day MA of 81.00, indicating a bearish trend. The MACD of -1.53 indicates Positive momentum. The RSI at 28.64 is Positive, neither overbought nor oversold. The STOCH value of 5.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹33.22B31.891.97%-8.66%-17.79%
64
Neutral
₹35.66B201.060.07%16.88%0.69%
63
Neutral
₹20.10B40.210.15%0.95%488.81%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
56
Neutral
₹26.62B25.340.88%2.73%-11.40%
55
Neutral
₹10.58B-52.702.00%4.65%-127.24%
46
Neutral
₹19.25B
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MOL
Meghmani Organics Limited
74.56
-24.79
-24.95%
IN:DCW
DCW Ltd.
67.24
-36.97
-35.48%
IN:FCL
Fineotex Chemical Limited
26.36
-10.41
-28.30%
IN:IOLCP
IOL Chemicals & Pharmaceuticals Ltd.
90.62
12.97
16.71%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,500.25
624.72
71.35%
IN:TNPL
Tamil Nadu Newsprint & Papers Ltd.
149.60
-19.54
-11.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025